Genmab — Januar 2024
-
“Blandt potentielle købere i 2024, ser vi Johnson & Johnson og Novo som mest tilbøjelige til at deltage i megahandler til en værdi af over 20 mia. dollar (136 mia. kr.), baseret på virksomhedernes opkøbsevne,” skriver Bank of America i en analyse af udviklingen på M&A for 2024. https://borsen.dk/nyheder/virksomheder/storbank-novo-nordisk-klar-til-megaopkob?b_source=borsen&b_medium=row_0&b_campaign=news_4
-
Novartis interested in Interleukin-15 https://www.b3cnewswire.com/202401082504/calypso-enters-into-agreement-to-be-acquired-by-novartis.html -we can't be too far away from getting data on PRV-015 i would imagine, maybe towards the summer
-
JNJ buying another ADC biotech , Ambrx https://finance.yahoo.com/news/johnson-johnson-acquire-ambrx-advancing-123000192.html
-
Merck buying a small Tcell engager biotech, Harpoon Therapeutics https://finance.yahoo.com/news/merck-acquire-harpoon-therapeutics-further-123000116.html
-
Johnson & Johnson i milliardopkøb på kræftområdet https://www.proinvestor.com/investornyt/1100387/johnson-johnson-i-milliardopkob-pa-kraeftomradet
-
"New Year’s Update and Outlook for My Epcoritamab Trial" https://cllsociety.org/2024/01/new-years-update-and-outlook-for-my-epcoritamab-trial/
-
Nice and uplifting reading E L. Thank you for the link!
-
Genmab handles pænt op i US . Lige nu i niveau 2224.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind